Neuronal nitric oxide synthase (NOS1) and its adaptor, NOS1AP, as a genetic risk factors for psychiatric disorders

Genes, Brain and Behavior

Volumn 14, Issue 1, 2015, Pages 46-63

  Freudenberg, F ^a   Alttoa, A ^b,c   Reif, A ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^b UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

^c UNIVERSITY OF TARTU   (Estonia)

Author keywords

ADHD; Biomarker; Bipolar disorder; Impulsivity; Major depression; Nitric oxide; NOx< inf>; NOS1AP; Polymorphism; Schizophrenia

Indexed keywords

ADAPTOR PROTEIN; BIOLOGICAL MARKER; NEURONAL NITRIC OXIDE SYNTHASE; NEURONAL NITRIC OXIDE SYNTHASE 1; NEURONAL NITRIC OXIDE SYNTHASE 1 AP; UNCLASSIFIED DRUG; NOS1 PROTEIN, HUMAN; NOS1AP PROTEIN, HUMAN; SIGNAL TRANSDUCING ADAPTOR PROTEIN;

BIPOLAR DISORDER; COGNITION; CORPUS STRIATUM; EXECUTIVE FUNCTION; FUNCTIONAL GENOMICS; GENE STRUCTURE; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC VARIABILITY; HUMAN; IMPULSIVENESS; MAJOR DEPRESSION; MENTAL DISEASE; MOTOR DYSFUNCTION; NONHUMAN; PHENOTYPE; PREFRONTAL CORTEX; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SCHIZOPHRENIA; ANIMAL; GENETIC PREDISPOSITION; GENETICS; METABOLISM;

ANIMALIA;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MENTAL DISORDERS; NITRIC OXIDE SYNTHASE TYPE I;

EID: 84922618391     PISSN: 16011848     EISSN: 1601183X     Source Type: Journal    
DOI: 10.1111/gbb.12193     Document Type: Review

References (185)

1. Abkevich, V., Camp, N.J., Hensel, C.H. et al. (2003) Predisposition locus for major depression at chromosome 12q22-12q23.2. Am J Hum Genet 73, 1271-1281.
2. Akpinar, A., Yaman, G.B., Demirdas, A. & Onal, S. (2013) Possible role of adrenomedullin and nitric oxide in major depression. Prog Neuropsychopharmacol Biol Psychiatry 46, 120-125.
3. Andreazza, A.C., Kapczinski, F., Kauer-Sant'Anna, M., Walz, J.C., Bond, D.J., Goncalves, C.A., Young, L.T. & Yatham, L.N. (2009) 3-Nitrotyrosine and glutathione antioxidant system in patients in the early and late stages of bipolar disorder. J Psychiatry Neurosci 34, 263-271.
4. Andreazza, A.C., Shao, L., Wang, J.F. & Young, L.T. (2010) Mitochondrial complex I activity and oxidative damage to mitochondrial proteins in the prefrontal cortex of patients with bipolar disorder. Arch Gen Psychiatry 67, 360-368.
5. Atmaca, M., Tezcan, E., Kuloglu, M. & Ustundag, B. (2005) Plasma nitrate values in patients with obsessive-compulsive disorder. Psychiatry Clin Neurosci 59, 621-623.
6. Atmaca, M., Tezcan, E. & Ustundag, B. (2007) Plasma nitric oxide and leptin values in patients with olanzapine-induced weight gain. J Psychiatr Res 41, 74-79.
7. Averbukh, M.L., Kas'ko, A.F., Nikolenko, E.S. & Rybas, I.I. (1966) On the diagnostic significance of Black's reaction in psychiatric patients. Lab Delo 5, 289-291.
8. Bennett, B.M., Reynolds, J.N., Prusky, G.T., Douglas, R.M., Sutherland, R.J. & Thatcher, G.R. (2007) Cognitive deficits in rats after forebrain cholinergic depletion are reversed by a novel NO mimetic nitrate ester. Neuropsychopharmacology 32, 505-513.
9. Bernstein, H.G., Becker, A., Keilhoff, G., Grecksch, G. & Bogerts, B. (2011a) Schizophrenia and the nitric oxide controversy: do all things fall into place now? Synapse 65, 545-546 author reply 547.
10. Bernstein, H.G., Bogerts, B. & Keilhoff, G. (2005) The many faces of nitric oxide in schizophrenia. A review. Schizophr Res 78, 69-86.
11. Bernstein, H.G., Keilhoff, G., Steiner, J., Dobrowolny, H. & Bogerts, B. (2011b) Nitric oxide and schizophrenia: present knowledge and emerging concepts of therapy. CNS Neurol Disord Drug Targets 10, 792-807.
12. Blum-Degen, D., Heinemann, T., Lan, J., Pedersen, V., Leblhuber, F., Paulus, W., Riederer, P. & Gerlach, M. (1999) Characterization and regional distribution of nitric oxide synthase in the human brain during normal ageing. Brain Res 834, 128-135.
13. Boissel, J.P., Schwarz, P.M. & Forstermann, U. (1998) Neuronal-type NO synthase: transcript diversity and expressional regulation. Nitric Oxide 2, 337-349.
14. Brenman, J.E., Chao, D.S., Gee, S.H., McGee, A.W., Craven, S.E., Santillano, D.R., Wu, Z., Huang, F., Xia, H., Peters, M.F., Froehner, S.C. & Bredt, D.S. (1996) Interaction of nitric oxide synthase with the postsynaptic density protein PSD-95 and alpha1-syntrophin mediated by PDZ domains. Cell 84, 757-767.
15. Brenman, J.E., Xia, H., Chao, D.S., Black, S.M. & Bredt, D.S. (1997) Regulation of neuronal nitric oxide synthase through alternative transcripts. Dev Neurosci 19, 224-231.
16. Bros, M., Boissel, J.P., Godtel-Armbrust, U. & Forstermann, U. (2006) Transcription of human neuronal nitric oxide synthase mRNAs derived from different first exons is partly controlled by exon 1-specific promoter sequences. Genomics 87, 463-473.
17. Brown, N.C., Andreazza, A.C. & Young, L.T. (2014) An updated meta-analysis of oxidative stress markers in bipolar disorder. Psychiatry Res 218, 61-68.
18. Brzustowicz, L.M. (2008) NOS1AP in schizophrenia. Curr Psychiatry Rep 10, 158-163.
19. Brzustowicz, L.M., Hodgkinson, K.A., Chow, E.W., Honer, W.G. & Bassett, A.S. (2000) Location of a major susceptibility locus for familial schizophrenia on chromosome 1q21-q22. Science 288, 678-682.
20. Brzustowicz, L.M., Simone, J., Mohseni, P., Hayter, J.E., Hodgkinson, K.A., Chow, E.W. & Bassett, A.S. (2004) Linkage disequilibrium mapping of schizophrenia susceptibility to the CAPON region of chromosome 1q22. Am J Hum Genet 74, 1057-1063.
21. Buttenschon, H.N., Mors, O., Ewald, H., McQuillin, A., Kalsi, G., Lawrence, J., Gurling, H. & Kruse, T.A. (2004) No association between a neuronal nitric oxide synthase (NOS1) gene polymorphism on chromosome 12q24 and bipolar disorder. Am J Med Genet 124B, 73-75.
22. Campbell, M.G., Kohane, I.S. & Kong, S.W. (2013) Pathway-based outlier method reveals heterogeneous genomic structure of autism in blood transcriptome. BMC Med Genomics 6, 34.
23. Chanrion, B., Mannoury la Cour, C., Bertaso, F., Lerner-Natoli, M., Freissmuth, M., Millan, M.J., Bockaert, J. & Marin, P. (2007) Physical interaction between the serotonin transporter and neuronal nitric oxide synthase underlies reciprocal modulation of their activity. Proc Natl Acad Sci USA 104, 8119-8124.
24. Chrapko, W., Jurasz, P., Radomski, M.W., Archer, S.L., Newman, S.C., Baker, G., Lara, N. & Le Melledo, J.M. (2006) Alteration of decreased plasma NO metabolites and platelet NO synthase activity by paroxetine in depressed patients. Neuropsychopharmacology 31, 1286-1293.
25. Chrapko, W.E., Jurasz, P., Radomski, M.W., Lara, N., Archer, S.L. & Le Melledo, J.M. (2004) Decreased platelet nitric oxide synthase activity and plasma nitric oxide metabolites in major depressive disorder. Biol Psychiatry 56, 129-134.
26. Christopherson, K.S., Hillier, B.J., Lim, W.A. & Bredt, D.S. (1999) PSD-95 assembles a ternary complex with the N-methyl-D-aspartic acid receptor and a bivalent neuronal NO synthase PDZ domain. J Biol Chem 274, 27467-27473.
27. Chung, K.K., Dawson, V.L. & Dawson, T.M. (2005) S-nitrosylation in Parkinson's disease and related neurodegenerative disorders. Methods Enzymol 396, 139-150.
28. Chung, K.K., Thomas, B., Li, X., Pletnikova, O., Troncoso, J.C., Marsh, L., Dawson, V.L. & Dawson, T.M. (2004) S-nitrosylation of parkin regulates ubiquitination and compromises parkin's protective function. Science 304, 1328-1331.
29. Cui, H., Nishiguchi, N., Yanagi, M., Fukutake, M., Mouri, K., Kitamura, N., Hashimoto, T., Shirakawa, O. & Hishimoto, A. (2010) A putative cis-acting polymorphism in the NOS1 gene is associated with schizophrenia and NOS1 immunoreactivity in the postmortem brain. Schizophr Res 121, 172-178.
30. Das, I., Khan, N.S., Puri, B.K. & Hirsch, S.R. (1996) Elevated endogenous nitric oxide synthase inhibitor in schizophrenic plasma may reflect abnormalities in brain nitric oxide production. Neurosci Lett 215, 209-211.
31. Das, I., Khan, N.S., Puri, B.K., Sooranna, S.R., de Belleroche, J. & Hirsch, S.R. (1995) Elevated platelet calcium mobilization and nitric oxide synthase activity may reflect abnormalities in schizophrenic brain. Biochem Biophys Res Commun 212, 375-380.
32. Delorme, R., Betancur, C., Scheid, I., Anckarsater, H., Chaste, P., Jamain, S., Schuroff, F., Nygren, G., Herbrecht, E., Dumaine, A., Mouren, M.C., Rastam, M., Leboyer, M., Gillberg, C. & Bourgeron, T. (2010) Mutation screening of NOS1AP gene in a large sample of psychiatric patients and controls. BMC Med Genet 11, 108.
33. Deutsch, S.I., Rosse, R.B., Schwartz, B.L., Fay-McCarthy, M., Rosenberg, P.B. & Fearing, K. (1997) Methylene blue adjuvant therapy of schizophrenia. Clin Neuropharmacol 20, 357-363.
34. Dhir, A. & Kulkarni, S.K. (2011) Nitric oxide and major depression. Nitric Oxide 24, 125-131.
35. Donohoe, G., Walters, J., Morris, D.W., Quinn, E.M., Judge, R., Norton, N., Giegling, I., Hartmann, A.M., Moller, H.J., Muglia, P., Williams, H., Moskvina, V., Peel, R., O'Donoghue, T., Owen, M.J., O'Donovan, M.C., Gill, M., Rujescu, D. & Corvin, A. (2009) Influence of NOS1 on verbal intelligence and working memory in both patients with schizophrenia and healthy control subjects. Arch Gen Psychiatry 66, 1045-1054.
36. Doucet, M.V., Harkin, A. & Dev, K.K. (2012) The PSD-95/nNOS complex: new drugs for depression? Pharmacol Ther 133, 218-229.
37. Eastwood, S.L. (2005) Does the CAPON gene confer susceptibility to schizophrenia? PLoS Med 2, e348.
38. Essa, M.M., Guillemin, G.J., Waly, M.I., Al-Sharbati, M.M., Al-Farsi, Y.M., Hakkim, F.L., Ali, A. & Al-Shafaee, M.S. (2012) Increased markers of oxidative stress in autistic children of the Sultanate of Oman. Biol Trace Elem Res 147, 25-27.
39. Fallin, M.D., Lasseter, V.K., Avramopoulos, D., Nicodemus, K.K., Wolyniec, P.S., McGrath, J.A., Steel, G., Nestadt, G., Liang, K.Y., Huganir, R.L., Valle, D. & Pulver, A.E. (2005) Bipolar I disorder and schizophrenia: a 440-single-nucleotide polymorphism screen of 64 candidate genes among Ashkenazi Jewish case-parent trios. Am J Hum Genet 77, 918-936.
40. Fang, C., Tang, W., Tang, R.Q., Wang, L., Zhou, G.Q., Huang, K., Li, X.W., Feng, G.Y., He, M., Du, L.Z., Zhu, S.M., Xing, Y.L., Sang, H., He, L. & Shi, Y.Y. (2008) Family-based association studies of CAPON and schizophrenia in the Chinese Han population. Prog Neuropsychopharmacol Biol Psychiatry 32, 1210-1213.
41. Fang, M., Jaffrey, S.R., Sawa, A., Ye, K., Luo, X. & Snyder, S.H. (2000) Dexras1: a G protein specifically coupled to neuronal nitric oxide synthase via CAPON. Neuron 28, 183-193.
42. Franke, B., Neale, B.M. & Faraone, S.V. (2009) Genome-wide association studies in ADHD. Hum Genet 126, 13-50.
43. Frye, R.E., Huffman, L.C. & Elliott, G.R. (2010) Tetrahydrobiopterin as a novel therapeutic intervention for autism. Neurotherapeutics 7, 241-249.
44. Galecki, P., Maes, M., Florkowski, A., Lewinski, A., Galecka, E., Bienkiewicz, M. & Szemraj, J. (2011) Association between inducible and neuronal nitric oxide synthase polymorphisms and recurrent depressive disorder. J Affect Disord 129, 175-182.
45. Galimberti, D., Scarpini, E., Venturelli, E., Strobel, A., Herterich, S., Fenoglio, C., Guidi, I., Scalabrini, D., Cortini, F., Bresolin, N., Lesch, K.P. & Reif, A. (2007) Association of a NOS1 promoter repeat with Alzheimer's disease. Neurobiol Aging 29, 1359-1365.
46. Galimberti, D., Venturelli, E., Gatti, A., Lovati, C., Fenoglio, C., Mariani, C., Forloni, G., Bresolin, N. & Scarpini, E. (2005) Association of neuronal nitric oxide synthase C276T polymorphism with Alzheimer's disease. J Neurol 252, 985-986.
47. Gao, S.F., Qi, X.R., Zhao, J., Balesar, R., Bao, A.M. & Swaab, D.F. (2013) Decreased NOS1 expression in the anterior cingulate cortex in depression. Cereb Cortex 23, 2956-2964.
48. Gattaz, W.F., Cramer, H. & Beckmann, H. (1983) Low CSF concentrations of cyclic GMP in schizophrenia. Br J Psychiatry 142, 288-291.
49. Gergerlioglu, H.S., Savas, H.A., Bulbul, F., Selek, S., Uz, E. & Yumru, M. (2007) Changes in nitric oxide level and superoxide dismutase activity during antimanic treatment. Prog Neuropsychopharmacol Biol Psychiatry 31, 697-702.
50. Grasemann, H., Drazen, J.M., Deykin, A., Israel, E., De Sanctis, G.T., Pillari, A. & Yandava, C.H. (1999) Simple tandem repeat polymorphisms in the neuronal nitric oxide synthase gene in different ethnic populations. Hum Hered 49, 139-141.
51. Grubina, R., Huang, Z., Shiva, S., Joshi, M.S., Azarov, I., Basu, S., Ringwood, L.A., Jiang, A., Hogg, N., Kim-Shapiro, D.B. & Gladwin, M.T. (2007) Concerted nitric oxide formation and release from the simultaneous reactions of nitrite with deoxy- and oxyhemoglobin. J Biol Chem 282, 12916-12927.
52. Hadzimichalis, N.M., Previtera, M.L., Moreau, M.P., Li, B., Lee, G.H., Dulencin, A.M., Matteson, P.G., Buyske, S., Millonig, J.H., Brzustowicz, L.M. & Firestein, B.L. (2010) NOS1AP protein levels are altered in BA46 and cerebellum of patients with schizophrenia. Schizophr Res 124, 248-250.
53. Hall, A.V., Antoniou, H., Wang, Y., Cheung, A.H., Arbus, A.M., Olson, S.L., Lu, W.C., Kau, C.-L. & Marsden, P.A. (1994) Structural organization of the human neuronal nitric oxide synthase gene (NOS1). J Biol Chem 269, 33082-33090.
54. Hallak, J.E.C., Maia-de-Oliveira, J.P., Abrao, J., Evora, P.R., Zuardi, A.W., Crippa, J.A.S., Belmonte-de-Abreu, P., Baker, G.B. & Dursun, S.M. (2013) Rapid improvement of acute schizophrenia symptoms after intravenous sodium nitroprusside. JAMA Psychiatry 70, 668-676.
55. Hancock, D.B., Martin, E.R., Vance, J.M. & Scott, W.K. (2008) Nitric oxide synthase genes and their interactions with environmental factors in Parkinson's disease. Neurogenetics 9, 249-262.
56. He, Y., Yu, Z., Giegling, I., Xie, L., Hartmann, A.M., Prehn, C., Adamski, J., Kahn, R., Li, Y., Illig, T., Wang-Sattler, R. & Rujescu, D. (2012) Schizophrenia shows a unique metabolomics signature in plasma. Transl Psychiatry 2, e149.
57. Herken, H., Akyol, O., Yilmaz, H.R., Tutkun, H., Savas, H.A., Ozen, M.E., Kalenderoglu, A. & Gulec, M. (2006) Nitric oxide, adenosine deaminase, xanthine oxidase and superoxide dismutase in patients with panic disorder: alterations by antidepressant treatment. Hum Psychopharmacol 21, 53-59.
58. Herken, H., Gurel, A., Selek, S., Armutcu, F., Ozen, M.E., Bulut, M., Kap, O., Yumru, M., Savas, H.A. & Akyol, O. (2007) Adenosine deaminase, nitric oxide, superoxide dismutase, and xanthine oxidase in patients with major depression: impact of antidepressant treatment. Arch Med Res 38, 247-252.
59. Herken, H., Uz, E., Ozyurt, H. & Akyol, O. (2001) Red blood cell nitric oxide levels in patients with schizophrenia. Schizophr Res 52, 289-290.
60. Hoekstra, R., Fekkes, D., Pepplinkhuizen, L., Loonen, A.J., Tuinier, S. & Verhoeven, W.M. (2006) Nitric oxide and neopterin in bipolar affective disorder. Neuropsychobiology 54, 75-81.
61. Hoogman, M., Aarts, E., Zwiers, M., Slaats-Willemse, D., Naber, M., Onnink, M., Cools, R., Kan, C., Buitelaar, J. & Franke, B. (2011) Nitric oxide synthase genotype modulation of impulsivity and ventral striatal activity in adult ADHD patients and healthy comparison subjects. Am J Psychiatry 168, 1099-1106.
62. Hyman, B.T., Marzloff, K., Wenniger, J.J., Dawson, T.M., Bredt, D.S. & Snyder, S.H. (1992) Relative sparing of nitric oxide synthase-containing neurons in the hippocampal formation in Alzheimer's disease. Ann Neurol 32, 818-820.
63. Jaffrey, S.R., Benfenati, F., Snowman, A.M., Czernik, A.J. & Snyder, S.H. (2002) Neuronal nitric-oxide synthase localization mediated by a ternary complex with synapsin and CAPON. Proc Natl Acad Sci USA 99, 3199-3204.
64. Jaffrey, S.R., Snowman, A.M., Eliasson, M.J., Cohen, N.A. & Snyder, S.H. (1998) CAPON: a protein associated with neuronal nitric oxide synthase that regulates its interactions with PSD95. Neuron 20, 115-124.
65. Jemth, P. & Gianni, S. (2007) PDZ domains: folding and binding. Biochemistry 46, 8701-8708.
66. Kawohl, W., Giegling, I., Mavrogiorgou, P., Pogarell, O., Mulert, C., Moller, H.J., Hegerl, U., Rujescu, D. & Juckel, G. (2008) Association of functional polymorphisms in NOS1 and NOS3 with loudness dependence of auditory evoked potentials. Int J Neuropsychopharmacol 11, 477-483.
67. Kaya, B., Unal, S., Karabulut, A.B. & Turkoz, Y. (2004) Altered diurnal variation of nitric oxide production in patients with panic disorder. Tohoku J Exp Med 204, 147-154.
68. Kim, H.W., Cho, S.C., Kim, J.W., Cho, I.H., Kim, S.A., Park, M., Cho, E.J. & Yoo, H.J. (2009) Family-based association study between NOS-I and -IIA polymorphisms and autism spectrum disorders in Korean trios. Am J Med Genet B Neuropsychiatr Genet 150B, 300-306.
69. Kim, Y.K., Paik, J.W., Lee, S.W., Yoon, D., Han, C. & Lee, B.H. (2006) Increased plasma nitric oxide level associated with suicide attempt in depressive patients. Prog Neuropsychopharmacol Biol Psychiatry 30, 1091-1096.
70. Kiss, J.P. & Vizi, E.S. (2001) Nitric oxide: a novel link between synaptic and nonsynaptic transmission. Trends Neurosci 24, 211-215.
71. Kittel-Schneider, S., Reuss, M., Meyer, A., Weber, H., Gessner, A., Leistner, C., Kopf, J., Schmidt, B., Hempel, S., Volkert, J., Lesch, K.P. & Reif, A. (2014) Multi-level biomarker analysis of nitric oxide synthase isoforms in bipolar disorder and adult ADHD. J Psychopharmacol 29, 31-38.
72. Kopf, J., Schecklmann, M., Hahn, T., Dieler, A.C., Herrmann, M.J., Fallgatter, A.J. & Reif, A. (2012) NOS1 ex1f-VNTR polymorphism affects prefrontal oxygenation during response inhibition tasks. Hum Brain Mapp 33, 2561-2571.
73. Kopf, J., Schecklmann, M., Hahn, T., Dresler, T., Dieler, A.C., Herrmann, M.J., Fallgatter, A.J. & Reif, A. (2011) NOS1 ex1f-VNTR polymorphism influences prefrontal brain oxygenation during a working memory task. Neuroimage 57, 1617-1623.
74. Kremeyer, B., Garcia, J., Kymalainen, H., Wratten, N., Restrepo, G., Palacio, C., Miranda, A.L., Lopez, C., Restrepo, M., Bedoya, G., Brzustowicz, L.M., Ospina-Duque, J., Arbelaez, M.P. & Ruiz-Linares, A. (2009) Evidence for a role of the NOS1AP (CAPON) gene in schizophrenia and its clinical dimensions: an association study in a South American population isolate. Hum Hered 67, 163-173.
75. Kurrikoff, T., Lesch, K.P., Kiive, E., Konstabel, K., Herterich, S., Veidebaum, T., Reif, A. & Harro, J. (2012) Association of a functional variant of the nitric oxide synthase 1 gene with personality, anxiety, and depressiveness. Dev Psychopathol 24, 1225-1235.
76. Laas, K., Reif, A., Herterich, S., Eensoo, D., Lesch, K.P. & Harro, J. (2010) The effect of a functional NOS1 promoter polymorphism on impulsivity is moderated by platelet MAO activity. Psychopharmacology (Berl) 209, 255-261.
77. Lakshmi Priya, M.D. & Geetha, A. (2011) A biochemical study on the level of proteins and their percentage of nitration in the hair and nail of autistic children. Clin Chim Acta 412, 1036-1042.
78. Lara, N., Archer, S.L., Baker, G.B. & Le Melledo, J.M. (2003) Paroxetine-induced increase in metabolic end products of nitric oxide. J Clin Psychopharmacol 23, 641-645.
79. Lasky-Su, J., Neale, B.M., Franke, B. et al. (2008) Genome-wide association scan of quantitative traits for attention deficit hyperactivity disorder identifies novel associations and confirms candidate gene associations. Am J Med Genet B Neuropsychiatr Genet 147B, 1345-1354.
80. Law, A., Gauthier, S. & Quirion, R. (2001) Say NO to Alzheimer's disease: the putative links between nitric oxide and dementia of the Alzheimer's type. Brain Res Brain Res Rev 35, 73-96.
81. Lee, B.H., Lee, S.W., Yoon, D., Lee, H.J., Yang, J.C., Shim, S.H., Kim, D.H., Ryu, S.H., Han, C. & Kim, Y.K. (2006) Increased plasma nitric oxide metabolites in suicide attempters. Neuropsychobiology 53, 127-132.
82. Lencz, T., Lambert, C., DeRosse, P., Burdick, K.E., Morgan, T.V., Kane, J.M., Kucherlapati, R. & Malhotra, A.K. (2007) Runs of homozygosity reveal highly penetrant recessive loci in schizophrenia. Proc Natl Acad Sci USA 104, 19942-19947.
83. Levecque, C., Elbaz, A., Clavel, J., Richard, F., Vidal, J.S., Amouyel, P., Tzourio, C., Alperovitch, A. & Chartier-Harlin, M.C. (2003) Association between Parkinson's disease and polymorphisms in the nNOS and iNOS genes in a community-based case-control study. Hum Mol Genet 12, 79-86.
84. Li, H.C., Chen, Q.Z., Ma, Y. & Zhou, J.F. (2006) Imbalanced free radicals and antioxidant defense systems in schizophrenia: a comparative study. J Zhejiang Univ Sci B 7, 981-986.
85. Liang, X., Schnetz-Boutaud, N., Kenealy, S.J., Jiang, L., Bartlett, J., Lynch, B., Gaskell, P.C., Gwirtsman, H., McFarland, L., Bembe, M.L., Bronson, P., Gilbert, J.R., Martin, E.R., Pericak-Vance, M.A. & Haines, J.L. (2006) Covariate analysis of late-onset Alzheimer disease refines the chromosome 12 locus. Mol Psychiatry 11, 280-285.
86. Liou, Y.J., Hong, C.J., Liu, H.C., Liu, C.Y., Liu, T.Y., Chen, I.C. & Tsai, S.J. (2002) No association between the neuronal nitric oxide synthase gene polymorphism and Alzheimer Disease. Am J Med Genet 114, 687-688.
87. Liou, Y.J., Tsai, S.J., Hong, C.J. & Liao, D.L. (2003) Association analysis for the CA repeat polymorphism of the neuronal nitric oxide synthase (NOS1) gene and schizophrenia. Schizophr Res 65, 57-59.
88. Lo, H.S., Hogan, E.L. & Soong, B.W. (2002) 5'-Flanking region polymorphism of the neuronal nitric oxide synthase gene with Parkinson's disease in Taiwan. J Neurol Sci 194, 11-13.
89. Luciano, M., Houlihan, L.M., Harris, S.E., Gow, A.J., Hayward, C., Starr, J.M. & Deary, I.J. (2010) Association of existing and new candidate genes for anxiety, depression and personality traits in older people. Behav Genet 40, 518-532.
90. Luciano, M., Huffman, J.E., Arias-Vasquez, A. et al. (2012) Genome-wide association uncovers shared genetic effects among personality traits and mood states. Am J Med Genet B Neuropsychiatr Genet 159B, 684-695.
91. Luth, H.J., Munch, G. & Arendt, T. (2002) Aberrant expression of NOS isoforms in Alzheimer's disease is structurally related to nitrotyrosine formation. Brain Res 953, 135-143.
92. Manso, H., Krug, T., Sobral, J., Albergaria, I., Gaspar, G., Ferro, J.M., Oliveira, S.A. & Vicente, A.M. (2012) Variants within the nitric oxide synthase 1 gene are associated with stroke susceptibility. Atherosclerosis 220, 443-448.
93. Marcourakis, T., Gorenstein, C., de Almeida, Brandao, Prado, E., Ramos, R.T., Glezer, I., Bernardes, C.S., Kawamoto, E.M. & Scavone, C. (2002) Panic disorder patients have reduced cyclic AMP in platelets. J Psychiatr Res 36, 105-110.
94. Miranda, A., Garcia, J., Lopez, C., Gordon, D., Palacio, C., Restrepo, G., Ortiz, J., Montoya, G., Cardeno, C., Calle, J., Lopez, M., Campo, O., Bedoya, G., Ruiz-Linares, A. & Ospina-Duque, J. (2006) Putative association of the carboxy-terminal PDZ ligand of neuronal nitric oxide synthase gene (CAPON) with schizophrenia in a Colombian population. Schizophr Res 82, 283-285.
95. Moghaddam, B. (2003) Bringing order to the glutamate chaos in schizophrenia. Neuron 40, 881-884.
96. Montesanto, A., Crocco, P., Tallaro, F., Pisani, F., Mazzei, B., Mari, V., Corsonello, A., Lattanzio, F., Passarino, G. & Rose, G. (2013) Common polymorphisms in nitric oxide synthase (NOS) genes influence quality of aging and longevity in humans. Biogerontology 14, 177-186.
97. Mufson, E.J. & Brandabur, M.M. (1994) Sparing of NADPH-diaphorase striatal neurons in Parkinson's and Alzheimer's diseases. Neuroreport 5, 705-708.
98. Narsapur, S.L. & Naylor, G.J. (1983) Methylene blue. A possible treatment for manic depressive psychosis. J Affect Disord 5, 155-161.
99. Naylor, G.J., Martin, B., Hopwood, S.E. & Watson, Y. (1986) A two-year double-blind crossover trial of the prophylactic effect of methylene blue in manic-depressive psychosis. Biol Psychiatry 21, 915-920.
100. Naylor, G.J., Smith, A.H. & Connelly, P. (1987) A controlled trial of methylene blue in severe depressive illness. Biol Psychiatry 22, 657-659.
101. Naylor, G.J., Smith, A.H. & Connelly, P. (1988) Methylene blue in mania. Biol Psychiatry 24, 941-942.
102. Nedvetsky, P.I., Sessa, W.C. & Schmidt, H.H. (2002) There's NO binding like NOS binding: protein-protein interactions in NO/cGMP signaling. Proc Natl Acad Sci USA 99, 16510-16512.
103. Nelson, R.J., Trainor, B.C., Chiavegatto, S. & Demas, G.E. (2006) Pleiotropic contributions of nitric oxide to aggressive behavior. Neurosci Biobehav Rev 30, 346-355.
104. Newton, D.C., Bevan, S.C., Choi, S., Robb, G.B., Millar, A., Wang, Y. & Marsden, P.A. (2003) Translational regulation of human neuronal nitric-oxide synthase by an alternatively spliced 5'-untranslated region leader exon. J Biol Chem 278, 636-644.
105. Nicodemus, K.K., Law, A.J., Radulescu, E., Luna, A., Kolachana, B., Vakkalanka, R., Rujescu, D., Giegling, I., Straub, R.E., McGee, K., Gold, B., Dean, M., Muglia, P., Callicott, J.H., Tan, H.Y. & Weinberger, D.R. (2010) Biological validation of increased schizophrenia risk with NRG1, ERBB4, and AKT1 epistasis via functional neuroimaging in healthy controls. Arch Gen Psychiatry 67, 991-1001.
106. Norris, P.J., Faull, R.L. & Emson, P.C. (1996) Neuronal nitric oxide synthase (nNOS) mRNA expression and NADPH-diaphorase staining in the frontal cortex, visual cortex and hippocampus of control and Alzheimer's disease brains. Brain Res Mol Brain Res 41, 36-49.
107. O'Donoghue, T., Morris, D.W., Fahey, C., Da Costa, A., Foxe, J.J., Hoerold, D., Tropea, D., Gill, M., Corvin, A. & Donohoe, G. (2012) A NOS1 variant implicated in cognitive performance influences evoked neural responses during a high density EEG study of early visual perception. Hum Brain Mapp 33, 1202-1211.
108. O'Donovan, M.C., Craddock, N., Norton, N. et al. (2008) Identification of loci associated with schizophrenia by genome-wide association and follow-up. Nat Genet 40, 1053-1055.
109. Ogilvie, P., Schilling, K., Billingsley, M.L. & Schmidt, H.H. (1995) Induction and variants of neuronal nitric oxide synthase type I during synaptogenesis. Faseb J 9, 799-806.
110. Okumura, T., Kishi, T., Okochi, T., Ikeda, M., Kitajima, T., Yamanouchi, Y., Kinoshita, Y., Kawashima, K., Tsunoka, T., Inada, T., Ozaki, N. & Iwata, N. (2010) Genetic association analysis of functional polymorphisms in neuronal nitric oxide synthase 1 gene (NOS1) and mood disorders and fluvoxamine response in major depressive disorder in the Japanese population. Neuropsychobiology 61, 57-63.
111. Okumura, T., Okochi, T., Kishi, T., Ikeda, M., Kitajima, T., Yamanouchi, Y., Kinoshita, Y., Kawashima, K., Tsunoka, T., Ujike, H., Inada, T., Ozaki, N. & Iwata, N. (2009) No association between polymorphisms of neuronal oxide synthase 1 gene (NOS1) and schizophrenia in a Japanese population. Neuromolecular Med 11, 123-127.
112. Pinto, V.L., de Souza, P.F., Brunini, T.M., Oliveira, M.B., Moss, M.B., Siqueira, M.A., Ferraz, M.R. & Mendes-Ribeiro, A.C. (2012) Low plasma levels of L-arginine, impaired intraplatelet nitric oxide and platelet hyperaggregability: implications for cardiovascular disease in depressive patients. J Affect Disord 140, 187-192.
113. Puri, V., McQuillin, A., Choudhury, K., Datta, S., Pimm, J., Thirumalai, S., Krasucki, R., Lawrence, J., Quested, D., Bass, N., Moorey, H., Morgan, J., Punukollu, B., Kandasami, G., Curtis, D. & Gurling, H. (2007) Fine mapping by genetic association implicates the chromosome 1q23.3 gene UHMK1, encoding a serine/threonine protein kinase, as a novel schizophrenia susceptibility gene. Biol Psychiatry 61, 873-879.
114. Puri, V., McQuillin, A., Thirumalai, S. et al. (2006) Failure to confirm allelic association between markers at the CAPON gene locus and schizophrenia in a British sample. Biol Psychiatry 59, 195-197.
115. Puzzo, D., Vitolo, O., Trinchese, F., Jacob, J.P., Palmeri, A. & Arancio, O. (2005) Amyloid-beta peptide inhibits activation of the nitric oxide/cGMP/cAMP-responsive element-binding protein pathway during hippocampal synaptic plasticity. J Neurosci 25, 6887-6897.
116. Ramirez, J., Garnica, R., Boll, M.C., Montes, S. & Rios, C. (2004) Low concentration of nitrite and nitrate in the cerebrospinal fluid from schizophrenic patients: a pilot study. Schizophr Res 68, 357-361.
117. Reif, A. (2010) Is NOS1 a genetic link between RLS and ADHD? J Psychiatr Res 44, 60-61.
118. Reif, A., Grunblatt, E., Herterich, S., Wichart, I., Rainer, M.K., Jungwirth, S., Danielczyk, W., Deckert, J., Tragl, K.H., Riederer, P. & Fischer, P. (2011a) Association of a functional NOS1 promoter repeat with Alzheimer's disease in the VITA cohort. J Alzheimers Dis 23, 327-333.
119. Reif, A., Herterich, S., Strobel, A., Ehlis, A.C., Saur, D., Jacob, C.P., Wienker, T., Topner, T., Fritzen, S., Walter, U., Schmitt, A., Fallgatter, A.J. & Lesch, K.P. (2006a) A neuronal nitric oxide synthase (NOS-I) haplotype associated with schizophrenia modifies prefrontal cortex function. Mol Psychiatry 11, 286-300.
120. Reif, A., Jacob, C.P., Rujescu, D., Herterich, S., Lang, S., Gutknecht, L., Baehne, C.G., Strobel, A., Freitag, C.M., Giegling, I., Romanos, M., Hartmann, A., Rosler, M., Renner, T.J., Fallgatter, A.J., Retz, W., Ehlis, A.C. & Lesch, K.P. (2009) Influence of functional variant of neuronal nitric oxide synthase on impulsive behaviors in humans. Arch Gen Psychiatry 66, 41-50.
121. Reif, A., Kiive, E., Kurrikoff, T., Paaver, M., Herterich, S., Konstabel, K., Tulviste, T., Lesch, K.P. & Harro, J. (2011b) A functional NOS1 promoter polymorphism interacts with adverse environment on functional and dysfunctional impulsivity. Psychopharmacology (Berl) 214, 239-248.
122. Reif, A., Schecklmann, M., Eirich, E., Jacob, C.P., Jarczok, T.A., Kittel-Schneider, S., Lesch, K.P., Fallgatter, A.J. & Ehlis, A.C. (2011c) A functional promoter polymorphism of neuronal nitric oxide synthase moderates prefrontal functioning in schizophrenia. Int J Neuropsychopharmacol 14, 887-897.
123. Reif, A., Strobel, A., Jacob, C.P., Herterich, S., Freitag, C.M., Topner, T., Mossner, R., Fritzen, S., Schmitt, A. & Lesch, K.P. (2006b) A NOS-III haplotype that includes functional polymorphisms is associated with bipolar disorder. Int J Neuropsychopharmacol 9, 13-20.
124. Riccio, A., Alvania, R.S., Lonze, B.E., Ramanan, N., Kim, T., Huang, Y., Dawson, T.M., Snyder, S.H. & Ginty, D.D. (2006) A nitric oxide signaling pathway controls CREB-mediated gene expression in neurons. Mol Cell 21, 283-294.
125. Richardson, M.A., Read, L.L., Reilly, M.A., Clelland, J.D. & Clelland, C.L. (2007) Analysis of plasma biopterin levels in psychiatric disorders suggests a common BH4 deficit in schizophrenia and schizoaffective disorder. Neurochem Res 32, 107-113.
126. Richardson, M.A., Read, L.L., Taylor Clelland, C.L., Reilly, M.A., Chao, H.M., Guynn, R.W., Suckow, R.F. & Clelland, J.D. (2005) Evidence for a tetrahydrobiopterin deficit in schizophrenia. Neuropsychobiology 52, 190-201.
127. Rife, T., Rasoul, B., Pullen, N., Mitchell, D., Grathwol, K. & Kurth, J. (2009) The effect of a promoter polymorphism on the transcription of nitric oxide synthase 1 and its relevance to Parkinson's disease. J Neurosci Res 87, 2319-2325.
128. Rife, T.K., Xie, J., Redman, C. & Young, A.P. (2000) The 5'2 promoter of the neuronal nitric oxide synthase dual promoter complex mediates inducibility by nerve growth factor. Brain Res Mol Brain Res 75, 225-236.
129. Riley, B., Thiselton, D., Maher, B.S., Bigdeli, T., Wormley, B., McMichael, G.O., Fanous, A.H., Vladimirov, V., O'Neill, F.A., Walsh, D. & Kendler, K.S. (2010) Replication of association between schizophrenia and ZNF804A in the Irish Case-control Study of Schizophrenia sample. Mol Psychiatry 15, 29-37.
130. Rose, E.J., Greene, C., Kelly, S., Morris, D.W., Robertson, I.H., Fahey, C., Jacobson, S., O'Doherty, J., Newell, F.N., McGrath, J., Bokde, A., Garavan, H., Frodl, T., Gill, M., Corvin, A.P. & Donohoe, G. (2012) The NOS1 variant rs6490121 is associated with variation in prefrontal function and grey matter density in healthy individuals. Neuroimage 60, 614-622.
131. Rujescu, D., Giegling, I., Mandelli, L., Schneider, B., Hartmann, A.M., Schnabel, A., Maurer, K., Moller, H.J. & Serretti, A. (2008) NOS-I and -III gene variants are differentially associated with facets of suicidal behavior and aggression-related traits. Am J Med Genet B Neuropsychiatr Genet 147B, 42-48.
132. Russwurm, M., Wittau, N. & Koesling, D. (2001) Guanylyl cyclase/PSD-95 interaction: targeting of the nitric oxide-sensitive alpha2beta1 guanylyl cyclase to synaptic membranes. J Biol Chem 276, 44647-44652.
133. Sarginson, J.E., Deakin, J.W., Anderson, I.M., Downey, D., Thomas, E., Elliott, R. & Juhasz, G. (2014) Neuronal nitric oxide synthase (NOS1) polymorphisms interact with financial hardship to affect depression risk. Neuropsychopharmacology 39, 2857-2866.
134. Saur, D., Neuhuber, W.L., Gengenbach, B., Huber, A., Schusdziarra, V. & Allescher, H.D. (2002a) Site-specific gene expression of nNOS variants in distinct functional regions of rat gastrointestinal tract. Am J Physiol Gastrointest Liver Physiol 282, G349-G358.
135. Saur, D., Seidler, B., Paehge, H., Schusdziarra, V. & Allescher, H.D. (2002b) Complex regulation of human neuronal nitric-oxide synthase exon 1c gene transcription. Essential role of Sp and ZNF family members of transcription factors. J Biol Chem 277, 25798-25814.
136. Saur, D., Vanderwinden, J.M., Seidler, B., Schmid, R.M., De Laet, M.H. & Allescher, H.D. (2004) Single-nucleotide promoter polymorphism alters transcription of neuronal nitric oxide synthase exon 1c in infantile hypertrophic pyloric stenosis. Proc Natl Acad Sci USA 101, 1662-1667.
137. Savas, H.A., Gergerlioglu, H.S., Armutcu, F., Herken, H., Yilmaz, H.R., Kocoglu, E., Selek, S., Tutkun, H., Zoroglu, S.S. & Akyol, O. (2006) Elevated serum nitric oxide and superoxide dismutase in euthymic bipolar patients: impact of past episodes. World J Biol Psychiatry 7, 51-55.
138. Savas, H.A., Herken, H., Yurekli, M., Uz, E., Tutkun, H., Zoroglu, S.S., Ozen, M.E., Cengiz, B. & Akyol, O. (2002) Possible role of nitric oxide and adrenomedullin in bipolar affective disorder. Neuropsychobiology 45, 57-61.
139. Selek, S., Savas, H.A., Gergerlioglu, H.S., Bulbul, F., Uz, E. & Yumru, M. (2008) The course of nitric oxide and superoxide dismutase during treatment of bipolar depressive episode. J Affect Disord 107, 89-94.
140. Selley, M.L. (2004) Increased (E)-4-hydroxy-2-nonenal and asymmetric dimethylarginine concentrations and decreased nitric oxide concentrations in the plasma of patients with major depression. J Affect Disord 80, 249-256.
141. Shinkai, T., Ohmori, O., Hori, H. & Nakamura, J. (2002) Allelic association of the neuronal nitric oxide synthase (NOS1) gene with schizophrenia. Mol Psychiatry 7, 560-563.
142. Silberberg, G., Ben-Shachar, D. & Navon, R. (2010) Genetic analysis of nitric oxide synthase 1 variants in schizophrenia and bipolar disorder. Am J Med Genet B Neuropsychiatr Genet 153B, 1318-1328.
143. Snyder, E.M., Nong, Y., Almeida, C.G., Paul, S., Moran, T., Choi, E.Y., Nairn, A.C., Salter, M.W., Lombroso, P.J., Gouras, G.K. & Greengard, P. (2005) Regulation of NMDA receptor trafficking by amyloid-beta. Nat Neurosci 8, 1051-1058.
144. Snyder, S.H. & Ferris, C.D. (2000) Novel neurotransmitters and their neuropsychiatric relevance. Am J Psychiatry 157, 1738-1751.
145. Sogut, S., Zoroglu, S.S., Ozyurt, H., Yilmaz, H.R., Ozugurlu, F., Sivasli, E., Yetkin, O., Yanik, M., Tutkun, H., Savas, H.A., Tarakcioglu, M. & Akyol, O. (2003) Changes in nitric oxide levels and antioxidant enzyme activities may have a role in the pathophysiological mechanisms involved in autism. Clin Chim Acta 331, 111-117.
146. Srivastava, N., Barthwal, M.K., Dalal, P.K., Agarwal, A.K., Nag, D., Seth, P.K., Srimal, R.C. & Dikshit, M. (2002) A study on nitric oxide, beta-adrenergic receptors and antioxidant status in the polymorphonuclear leukocytes from the patients of depression. J Affect Disord 72, 45-52.
147. Srivastava, N., Barthwal, M.K., Dalal, P.K., Agarwal, A.K., Nag, D., Srimal, R.C., Seth, P.K. & Dikshit, M. (2001) Nitrite content and antioxidant enzyme levels in the blood of schizophrenia patients. Psychopharmacology (Berl) 158, 140-145.
148. Sullivan, P.F., de Geus, E.J., Willemsen, G. et al. (2009) Genome-wide association for major depressive disorder: a possible role for the presynaptic protein piccolo. Mol Psychiatry 14, 359-375.
149. Suzuki, E., Nakaki, T., Nakamura, M. & Miyaoka, H. (2003) Plasma nitrate levels in deficit versus non-deficit forms of schizophrenia. J Psychiatry Neurosci 28, 288-292.
150. Suzuki, E., Yagi, G., Nakaki, T., Kanba, S. & Asai, M. (2001) Elevated plasma nitrate levels in depressive states. J Affect Disord 63, 221-224.
151. Sweeten, T.L., Posey, D.J., Shankar, S. & McDougle, C.J. (2004) High nitric oxide production in autistic disorder: a possible role for interferon-gamma. Biol Psychiatry 55, 434-437.
152. Talarowska, M., Galecki, P., Maes, M., Orzechowska, A., Chamielec, M., Bartosz, G. & Kowalczyk, E. (2012) Nitric oxide plasma concentration associated with cognitive impairment in patients with recurrent depressive disorder. Neurosci Lett 510, 127-131.
153. Taneli, F., Pirildar, S., Akdeniz, F., Uyanik, B.S. & Ari, Z. (2004) Serum nitric oxide metabolite levels and the effect of antipsychotic therapy in schizophrenia. Arch Med Res 35, 401-405.
154. Tang, W., Huang, K., Tang, R., Zhou, G., Fang, C., Zhang, J., Du, L., Feng, G., He, L. & Shi, Y. (2008) Evidence for association between the 5' flank of the NOS1 gene and schizophrenia in the Chinese population. Int J Neuropsychopharmacol 11, 1063-1071.
155. Texereau, J., Marullo, S., Hubert, D., Coste, J., Dusser, D.J., Dall'Ava-Santucci, J. & Dinh-Xuan, A.T. (2004) Nitric oxide synthase 1 as a potential modifier gene of decline in lung function in patients with cystic fibrosis. Thorax 59, 156-158.
156. Thomas, R.D. & Callender, K. (1985) Methylene blue in treatment of bipolar illness. Biol Psychiatry 20, 120-121.
157. Thorns, V., Hansen, L. & Masliah, E. (1998) nNOS expressing neurons in the entorhinal cortex and hippocampus are affected in patients with Alzheimer's disease. Exp Neurol 150, 14-20.
158. Tostes, M.H., Teixeira, H.C., Gattaz, W.F., Brandao, M.A. & Raposo, N.R. (2012) Altered neurotrophin, neuropeptide, cytokines and nitric oxide levels in autism. Pharmacopsychiatry 45, 241-243.
159. Turner, W.J. (1985) Methylene blue for MDI. Biol Psychiatry 20, 815.
160. Vincent, S.R., Johansson, O., Skirboll, L. & Hokfelt, T. (1982) Coexistence of somatostatin- and avian pancreatic polypeptide-like immunoreactivities in striatal neurons which are selectively stained for NADPH-diaphorase activity. Adv Biochem Psychopharmacol 33, 453-462.
161. Volkmann, J., Daniels, C. & Witt, K. (2010) Neuropsychiatric effects of subthalamic neurostimulation in Parkinson disease. Nat Rev Neurol 6, 487-498.
162. Wallerath, T., Gath, I., Aulitzky, W.E., Pollock, J.S., Kleinert, H. & Förstermann, U. (1997) Identification of the NO synthase isoforms expressed in human neutrophil granulocytes, megakaryocytes and platelets. Thromb Haemost 77, 163-167.
163. Wang, J., Ma, X.H., Xiang, B., Wu, J.Y., Wang, Y.C., Deng, W., Li, M.L., Wang, Q., He, Z.L. & Li, T. (2012) Association study of NOS1 gene polymorphisms and schizophrenia. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 29, 459-463.
164. Wang, Y., Goligorsky, M.S., Lin, M., Wilcox, J.N. & Marsden, P.A. (1997) A novel, testis-specific mRNA transcript encoding an NH2-terminal truncated nitric-oxide synthase. J Biol Chem 272, 11392-11401.
165. Wang, Y., Newton, D.C. & Marsden, P.A. (1999) Neuronal NOS: gene structure, mRNA diversity, and functional relevance. Crit Rev Neurobiol 13, 21-43.
166. Wass, C., Klamer, D., Katsarogiannis, E., Palsson, E., Svensson, L., Fejgin, K., Bogren, I.B., Engel, J.A. & Rembeck, B. (2011) L-lysine as adjunctive treatment in patients with schizophrenia: a single-blinded, randomized, cross-over pilot study. BMC Med 9, 40.
167. Weber, H., Klamer, D., Freudenberg, F. et al. (2014) The genetic contribution of the NO system at the glutamatergic post-synapse to schizophrenia: further evidence and meta-analysis. Eur Neuropsychopharmacol 24, 65-85.
168. West, A.R., Galloway, M.P. & Grace, A.A. (2002) Regulation of striatal dopamine neurotransmission by nitric oxide: effector pathways and signaling mechanisms. Synapse 44, 227-245.
169. Winkelmann, J., Lichtner, P., Schormair, B., Uhr, M., Hauk, S., Stiasny-Kolster, K., Trenkwalder, C., Paulus, W., Peglau, I., Eisensehr, I., Illig, T., Wichmann, H.E., Pfister, H., Golic, J., Bettecken, T., Putz, B., Holsboer, F., Meitinger, T. & Muller-Myhsok, B. (2008) Variants in the neuronal nitric oxide synthase (nNOS, NOS1) gene are associated with restless legs syndrome. Mov Disord 23, 350-358.
170. Wockner, L.F., Noble, E.P., Lawford, B.R., Young, R.M., Morris, C.P., Whitehall, V.L. & Voisey, J. (2014) Genome-wide DNA methylation analysis of human brain tissue from schizophrenia patients. Transl Psychiatry 4, e339.
171. Wratten, N.S., Memoli, H., Huang, Y., Dulencin, A.M., Matteson, P.G., Cornacchia, M.A., Azaro, M.A., Messenger, J., Hayter, J.E., Bassett, A.S., Buyske, S., Millonig, J.H., Vieland, V.J. & Brzustowicz, L.M. (2009) Identification of a schizophrenia-associated functional noncoding variant in NOS1AP. Am J Psychiatry 166, 434-441.
172. Wultsch, T., Chourbaji, S., Fritzen, S., Kittelt, S., Grunblatt, E., Gerlach, M., Gutknecht, L., Chizat, F., Golfier, G., Schmitt, A., Gass, P., Lesch, K.P. & Reif, A. (2007) Behavioural and expressional phenotyping of nitric oxide synthase-I knockdown animals. J Neural Transm Suppl (Suppl. 72), 69-85.
173. Xie, J., Roddy, P., Rife, T.K., Murad, F. & Young, A.P. (1995) Two closely linked but separable promoters for human neuronal nitric oxide synthase gene transcription. Proc Natl Acad Sci USA 92, 1242-1246.
174. Xu, B., Wratten, N., Charych, E.I., Buyske, S., Firestein, B.L. & Brzustowicz, L.M. (2005) Increased expression in dorsolateral prefrontal cortex of CAPON in schizophrenia and bipolar disorder. PLoS Med 2, e263.
175. Yanik, M., Vural, H., Kocyigit, A., Tutkun, H., Zoroglu, S.S., Herken, H., Savas, H.A., Koylu, A. & Akyol, O. (2003) Is the arginine-nitric oxide pathway involved in the pathogenesis of schizophrenia? Neuropsychobiology 47, 61-65.
176. Yanik, M., Vural, H., Tutkun, H., Zoroglu, S.S., Savas, H.A., Herken, H., Kocyigit, A., Keles, H. & Akyol, O. (2004) The role of the arginine-nitric oxide pathway in the pathogenesis of bipolar affective disorder. Eur Arch Psychiatry Clin Neurosci 254, 43-47.
177. Yao, J.K., Leonard, S. & Reddy, R.D. (2004) Increased nitric oxide radicals in postmortem brain from patients with schizophrenia. Schizophr Bull 30, 923-934.
178. Yilmaz, N., Herken, H., Cicek, H.K., Celik, A., Yurekli, M. & Akyol, O. (2007) Increased levels of nitric oxide, cortisol and adrenomedullin in patients with chronic schizophrenia. Med Princ Pract 16, 137-141.
179. Yu, Y.W., Chen, T.J., Wang, Y.C., Liou, Y.J., Hong, C.J. & Tsai, S.J. (2003) Association analysis for neuronal nitric oxide synthase gene polymorphism with major depression and fluoxetine response. Neuropsychobiology 47, 137-140.
180. Zabel, U., Kleinschnitz, C., Oh, P., Nedvetsky, P., Smolenski, A., Muller, H., Kronich, P., Kugler, P., Walter, U., Schnitzer, J.E. & Schmidt, H.H. (2002) Calcium-dependent membrane association sensitizes soluble guanylyl cyclase to nitric oxide. Nat Cell Biol 4, 307-311.
181. Zhang, T., Haws, P. & Wu, Q. (2004) Multiple variable first exons: a mechanism for cell- and tissue-specific gene regulation. Genome Res 14, 79-89.
182. Zheng, Y., Li, H., Qin, W., Chen, W., Duan, Y., Xiao, Y., Li, C., Zhang, J., Li, X., Feng, G. & He, L. (2005) Association of the carboxyl-terminal PDZ ligand of neuronal nitric oxide synthase gene with schizophrenia in the Chinese Han population. Biochem Biophys Res Commun 328, 809-815.
183. Zhou, L. & Zhu, D.Y. (2009) Neuronal nitric oxide synthase: structure, subcellular localization, regulation, and clinical implications. Nitric Oxide 20, 223-230.
184. Zoroglu, S.S., Herken, H., Yurekli, M., Uz, E., Tutkun, H., Savas, H.A., Bagci, C., Ozen, M.E., Cengiz, B., Cakmak, E.A., Dogru, M.I. & Akyol, O. (2002) The possible pathophysiological role of plasma nitric oxide and adrenomedullin in schizophrenia. J Psychiatr Res 36, 309-315.
185. Zoroglu, S.S., Yurekli, M., Meram, I., Sogut, S., Tutkun, H., Yetkin, O., Sivasli, E., Savas, H.A., Yanik, M., Herken, H. & Akyol, O. (2003) Pathophysiological role of nitric oxide and adrenomedullin in autism. Cell Biochem Funct 21, 55-60.